Your browser doesn't support javascript.
loading
Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries.
Blagec, Kathrin; Swen, Jesse J; Koopmann, Rudolf; Cheung, Ka-Chun; Crommentuijn-van Rhenen, Mandy; Holsappel, Inge; Konta, Lidija; Ott, Simon; Steinberger, Daniela; Xu, Hong; Cecchin, Erika; Dolzan, Vita; Dávila-Fajardo, Cristina Lucía; Patrinos, George P; Sunder-Plassmann, Gere; Turner, Richard M; Pirmohamed, Munir; Guchelaar, Henk-Jan; Samwald, Matthias.
Afiliación
  • Blagec K; Institute of Artificial Intelligence, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Swen JJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Koopmann R; Diagnosticum Center for Human Genetics, Frankfurt am Main, Germany.
  • Cheung KC; Institute for Human Genetics, Justus Liebig University, Giessen, Germany.
  • Crommentuijn-van Rhenen M; Medicines Information Centre, Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands.
  • Holsappel I; Medicines Information Centre, Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands.
  • Konta L; Medicines Information Centre, Royal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands.
  • Ott S; Diagnosticum Center for Human Genetics, Frankfurt am Main, Germany.
  • Steinberger D; Institute of Artificial Intelligence, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Xu H; Diagnosticum Center for Human Genetics, Frankfurt am Main, Germany.
  • Cecchin E; Institute for Human Genetics, Justus Liebig University, Giessen, Germany.
  • Dolzan V; Institute of Artificial Intelligence, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Dávila-Fajardo CL; Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • Patrinos GP; Faculty of Medicine, Institute of Biochemistry and Molecular Genetics, Pharmacogenetics Laboratory, University of Ljubljana, Ljubljana, Slovenia.
  • Sunder-Plassmann G; Clinical Pharmacy Department, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria Granada (Ibs.Granada), Granada, Spain.
  • Turner RM; Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy, University of Patras School of Health Sciences, Patras, Greece.
  • Pirmohamed M; Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Guchelaar HJ; The Wolfson Centre for Personalised Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  • Samwald M; Department of Molecular and Clinical Pharmacology, Royal Liverpool University Hospital and University of Liverpool, Liverpool, United Kingdom.
PLoS One ; 17(6): e0268534, 2022.
Article en En | MEDLINE | ID: mdl-35675343

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacogenética / Sistemas de Apoyo a Decisiones Clínicas Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacogenética / Sistemas de Apoyo a Decisiones Clínicas Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Austria
...